UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

PD-1 Blockade in Anaplastic Thyroid Carcinoma

Journal of clinical oncology, 2020-08, Vol.38 (23), p.2620-2627

2020

Volltextzugriff (PDF)

Next generation sequencing to define prokaryotic and fungal diversity in the bovine rumen

PloS one, 2012-11, Vol.7 (11), p.e48289-e48289

2012

Volltextzugriff (PDF)

Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury

Journal of translational medicine, 2012-08, Vol.10 (1), p.174-174, Article 174

2012

Volltextzugriff (PDF)

Genomic Profiling of Metastatic Uveal Melanoma and Clinical Results of a Phase I Study of the Protein Kinase C Inhibitor AEB071

Molecular cancer therapeutics, 2020-04, Vol.19 (4), p.1031-1039

2020

Volltextzugriff (PDF)

Sabatolimab in combination with spartalizumab in patients with non-small cell lung cancer or melanoma who received prior treatment with anti-PD-1/PD-L1 therapy: a phase 2 multicentre study

BMJ open, 2024-08, Vol.14 (8), p.e079132

2024

Volltextzugriff (PDF)

MicroRNA signatures differentiate melanoma subtypes

Cell cycle (Georgetown, Tex.), 2011-06, Vol.10 (11), p.1845-1852

2011

Volltextzugriff (PDF)

Loss of epigenetic silencing in tumors preferentially affects primate-specific retroelements

Gene, 2009-12, Vol.448 (2), p.151-167

2009

Volltextzugriff (PDF)

Phosphoproteomic screen identifies potential therapeutic targets in melanoma

Molecular cancer research, 2011-06, Vol.9 (6), p.801-812

2011

Volltextzugriff (PDF)

Sequence-Specific Biosensors Report Drug-Induced Changes in Epigenetic Silencing in Living Cells

DNA and cell biology, 2012-10, Vol.31 (S1), p.S-2-S-10

2012

Volltextzugriff (PDF)

Genetic landscape of ALK+ non-small cell lung cancer (NSCLC) patients (pts) and response to ceritinib in ASCEND-1

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.9064-9064

2016

Volltextzugriff (PDF)

Phase II, Randomized Study of Spartalizumab (PDR001), an Anti-PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Clinical cancer research, 2021-12, Vol.27 (23), p.6413-6423

2021

Volltextzugriff (PDF)

Phase 2 Study of the HSP-90 Inhibitor AUY922 in Previously Treated and Molecularly Defined Patients with Advanced Non–Small Cell Lung Cancer

Journal of thoracic oncology, 2018-04, Vol.13 (4), p.576-584

2018

Volltextzugriff (PDF)

Using Semantic Web Technologies to Annotate and Align Microarray Designs

Cancer informatics, 2009-01, Vol.2009 (Semantic Technologies Special Issue (2009)), p.65-73

2009

Volltextzugriff (PDF)

Abstract CT034: Phase I study of WNT974 + spartalizumab in patients (pts) with advanced solid tumors

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.CT034-CT034

2020

Volltextzugriff (PDF)

Using Bayesian modelling to investigate factors governing antibiotic-induced Candida albicans colonization of the GI tract

Scientific reports, 2015-02, Vol.5 (1), p.8131-8131, Article 8131

2015

Volltextzugriff (PDF)

Efficacy and safety of buparlisib, a PI3K inhibitor, in patients with malignancies harboring a PI3K pathway activation: a phase 2, open-label, single-arm study

Oncotarget, 2019-11, Vol.10 (60), p.6526-6535

2019

Volltextzugriff (PDF)

Phase Ib Study of the Anti-TIM-3 Antibody MBG453 in Combination with Decitabine in Patients with High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

Blood, 2019-11, Vol.134 (Supplement_1), p.570-570

2019

Volltextzugriff (PDF)

A mutation-specific, single-arm, phase 2 study of dovitinib in patients with advanced malignancies

Oncotarget, 2020-04, Vol.11 (14), p.1235-1243

2020

Volltextzugriff (PDF)

Abstract CT150: Phase II study of spartalizumab (PDR001) vs chemotherapy (CT) in patients with recurrent/metastatic nasopharyngeal cancer (NPC)

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.CT150-CT150

2019

Volltextzugriff (PDF)

Microbiome in human health and disease

Science progress (1916), 2013-06, Vol.96 (2), p.153-170

2013

Volltextzugriff (PDF)

MU2A—reconciling the genome and transcriptome to determine the effects of base substitutions

Bioinformatics, 2011-02, Vol.27 (3), p.416-418

2011

Volltextzugriff (PDF)

A systematic evaluation of high-dimensional, ensemble-based regression for exploring large model spaces in microbiome analyses

BMC bioinformatics, 2015-02, Vol.16 (1), p.31-31, Article 31

2015

Volltextzugriff (PDF)

AML-190: Anti-TIM-3 Antibody MBG453 in Combination with Hypomethylating Agents (HMAs) in Patients with High-Risk Myelodysplastic Syndrome (HR-MDS) and Acute Myeloid Leukemia: A Phase 1 Study

Clinical lymphoma, myeloma and leukemia, 2020-09, Vol.20, p.S188-S189

2020

Volltextzugriff (PDF)

Genomic mutation profiling (GMP) and clinical outcome of patients treated with buparlisib (PI3K inhibitor) in the “Signature” program

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.2516-2516

2015

Volltextzugriff (PDF)

Sequence-specific biosensors report drug-induced changes in epigenetic silencing in living cells

DNA and cell biology, 2012-10, Vol.31 Suppl 1, p.S2

2012

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(29)
Dissertationen
(1)

Sprache

Englisch
(30)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(16)
Life Sciences & Biomedicine
(14)
Humans
(12)
Oncology
(7)
Female
(6)
Male
(5)
Adult
(4)
Biochemistry & Molecular Biology
(4)
Middle Aged
(4)
Aged
(3)
Aged, 80 And Over
(3)
Animals
(3)
Biology
(3)
Cell Biology
(3)
Genomics
(3)
Mathematical & Computational Biology
(3)
Melanoma - Drug Therapy
(3)
Microbiota
(3)
Semantic Web
(3)
Adolescent
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

PD-1 Blockade in Anaplastic Thyroid Carcinoma

Next generation sequencing to define prokaryotic and fungal diversity in the bovine rumen

Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury

Genomic Profiling of Metastatic Uveal Melanoma and Clinical Results of a Phase I Study of the Protein Kinase C Inhibitor AEB071

Sabatolimab in combination with spartalizumab in patients with non-small cell lung cancer or melanoma who received prior treatment with anti-PD-1/PD-L1 therapy: a phase 2 multicentre study

MicroRNA signatures differentiate melanoma subtypes

Loss of epigenetic silencing in tumors preferentially affects primate-specific retroelements

Phosphoproteomic screen identifies potential therapeutic targets in melanoma

Sequence-Specific Biosensors Report Drug-Induced Changes in Epigenetic Silencing in Living Cells

Genetic landscape of ALK+ non-small cell lung cancer (NSCLC) patients (pts) and response to ceritinib in ASCEND-1

Phase II, Randomized Study of Spartalizumab (PDR001), an Anti-PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Phase 2 Study of the HSP-90 Inhibitor AUY922 in Previously Treated and Molecularly Defined Patients with Advanced Non–Small Cell Lung Cancer

Using Semantic Web Technologies to Annotate and Align Microarray Designs

Abstract CT034: Phase I study of WNT974 + spartalizumab in patients (pts) with advanced solid tumors

Using Bayesian modelling to investigate factors governing antibiotic-induced Candida albicans colonization of the GI tract

Efficacy and safety of buparlisib, a PI3K inhibitor, in patients with malignancies harboring a PI3K pathway activation: a phase 2, open-label, single-arm study

Phase Ib Study of the Anti-TIM-3 Antibody MBG453 in Combination with Decitabine in Patients with High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

A mutation-specific, single-arm, phase 2 study of dovitinib in patients with advanced malignancies

Abstract CT150: Phase II study of spartalizumab (PDR001) vs chemotherapy (CT) in patients with recurrent/metastatic nasopharyngeal cancer (NPC)

Microbiome in human health and disease

MU2A—reconciling the genome and transcriptome to determine the effects of base substitutions

A systematic evaluation of high-dimensional, ensemble-based regression for exploring large model spaces in microbiome analyses

AML-190: Anti-TIM-3 Antibody MBG453 in Combination with Hypomethylating Agents (HMAs) in Patients with High-Risk Myelodysplastic Syndrome (HR-MDS) and Acute Myeloid Leukemia: A Phase 1 Study

Genomic mutation profiling (GMP) and clinical outcome of patients treated with buparlisib (PI3K inhibitor) in the “Signature” program

Sequence-specific biosensors report drug-induced changes in epigenetic silencing in living cells

Suchergebnisse filtern